Health
Ear infections in young children could lead to delayed speech for them, study finds
Chronic ear infections could delay a child’s language development, new research suggests.
University of Florida researchers launched a study about how the common childhood infection could impact speech.
Early ear infections (otitis media) have the potential to impair hearing due to fluid buildup behind the eardrum, according to the study, which was published in the International Journal of Pediatric Otorhinolaryngology in November 2023.
HEARING AID USE COULD HELP PEOPLE EXTEND THEIR LIVES, USC STUDY FINDS
Researchers investigated the auditory processing and language development of 117 kids between 5 and 10 years of age, including those with and without a history of chronic ear infections.
Children who experienced several ear infections before turning 3 had a smaller vocabulary and found it difficult to match similar-sounding words.
Early ear infections could lead to a later delay in speech, according to a study from the University of Florida. (iStock)
These children also had a hard time detecting changes in sound, which could signify a problem in the brain’s auditory processing center.
Study co-author and UF professor Susan Nittrouer, PhD, discussed the findings in a statement to Fox News Digital.
“For most children, language development appears to unfold so effortlessly that it is easy for us to lose sight of what a remarkable feat this is,” she said.
AS AMOXICILLIN SHORTAGE CONTINUES, PRESCRIPTIONS HAVE PLUMMETED, STUDY FINDS
“And ear infections are so common among infants and toddlers that it is easy to view them as completely benign,” she added.
The study uncovered “two somewhat novel findings,” Nittrouer noted.
It’s important for guardians to pay attention to their children’s ear infection history, said the study’s lead researcher (not pictured). (iStock)
The first finding is the association of ear infections with poorer abilities to recognize patterns in the acoustic signals present in speech.
“The central auditory pathways develop after birth,” the researcher said.
“If enough auditory input is not available to the child – which happens with temporary periods of hearing loss due to ear infections – that development of auditory pathways is delayed and these listening abilities do not develop properly.”
SPIDER CRAWLS OUT OF A WOMAN’S EAR IN ‘TRAUMATIC’ EXPERIENCE AS TIKTOK GOES VIRAL: ‘CRYING, THROWING UP’
The second finding implied that this poor recognition of acoustic patterns impairs the ability of children to identify specific speech sounds, including elements like syllables.
“As they get older, the language they encounter, especially in school, becomes more complex and more dependent on that level of language structure.”
“This is a critical finding,” Nittrouer said. “During early periods of language acquisition, children do not have or need keen sensitivity to phonological structure – individual speech sounds.”
She added, “But as they get older, the language they encounter, especially in school, becomes more complex and more dependent on that level of language structure and the child’s ability to accurately and quickly recognize the individual speech sounds in words.”
One of the study’s “critical findings” was that ear infections can cause poor identification of speech sounds, the lead researcher said. (iStock)
This means that children who are delayed and challenged in their language development will “experience stronger challenges” as they get older, Nittrouer said.
“Contrary to the idea that the child will ‘get over’ or ‘outgrow’ the effects of early [ear infections], these effects may actually intensify,” she said.
“We must take every ear infection seriously.”
Nittrouer encouraged parents and caregivers to monitor children for “language-learning, academic and attentional difficulties,” including reading disabilities, as they age.
“It also means that we must take every ear infection seriously,” she added.
Other early health histories can delay a child’s speech as well, Nittrouer said — which means kids should be monitored for language development “well past the early school years.”
She also said that “the problems arising from such conditions may only present themselves as the language demands of school increase.”
Ear infections can delay the development of auditory pathways in early childhood, the study found. (iStock)
Cedars Sinai Guerin Children’s pediatric otolaryngologist Abhita Reddy, M.D., who was not involved in the study, told Fox News Digital she feels that in her view, the research is “under-powered.”
“The experiment had very few subjects studied and yet drew a broad conclusion from them,” the Los Angeles-based doctor said via email. “When a study has such few subjects in their experiment, often the conclusions can be easily skewed by confounding variables.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Reddy also pointed out that the chosen population of patients studied was “concerning,” as the study looked at children who reportedly did not have many ear infections as defined by parents.
“[This] can introduce a lot of concern regarding the type of otitis media the child had, as there are two types – acute otitis media and chronic otitis media with effusion – that can have very different effects on patients’ language development,” she said.
The effects of early ear infections could “intensify” as a child grows up, according to the researchers’ findings. (iStock)
The definition of patients who had experienced ear infections was “even more concerning,” Reddy said, since the authors apparently studied patients who had never received ear tubes.
“They did not mention whether the patient had ear tubes during the time of [the] experiment, how many sets they had or what the indications for their ear tubes were,” she said.
The specialist said that in her opinion, parents shouldn’t draw conclusions from this study and she does not believe the research will impact the future of ENT care.
“We know that recurrent acute otitis media in certain patients can be caused by eustachian tube dysfunction (a tube in our bodies that connects the middle ear space to the back of the nose) … [which], if not treated early, can lead to lifelong issues with hearing in the form of conductive hearing loss (ability for sound to transmit to the hearing nerve),” Reddy added.
For more Health articles, visit www.foxnews.com/health.
New flu strain emerging as a severe health threat
Fox News senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to warn of a new strain of the flu that is spiking hospitalizations across the country and newfound risks of medical marijuana’s link to psychosis.
NEWYou can now listen to Fox News articles!
A new form of the flu, which is highly contagious and aggressive, is sweeping the nation this season.
A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S.
The World Health Organization stated on its website that the K variant marks “a notable evolution in influenza A (H3N2) viruses,” which some say calls into question the effectiveness of this season’s influenza vaccine against the strain.
‘AGGRESSIVE’ NEW FLU VARIANT SWEEPS GLOBE AS DOCTORS WARN OF SEVERE SYMPTOMS
The K variant causes more intense flu symptoms, including fever, chills, headache, fatigue, cough, sore throat and runny nose, according to experts.
Multiple states in the northeast are reporting high rates of respiratory illness this month. (iStock)
Among 216 influenza A(H3N2) viruses collected since Sept. 28, 89.8% belonged to subclade K, a CDC report states.
The agency continues to release a weekly influenza surveillance report, tracking which states are seeing the most activity for outpatient respiratory illness.
5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS
Below are the states and regions within the highest range of reported medical visits, not necessarily confirmed influenza cases, as of the week ending Dec. 13.
The CDC’s weekly influenza surveillance report, an outpatient respiratory illness activity map, based on data reported to ILINet for the week ending Dec. 13, 2025. (CDC FluView)
Very High (Level 1)
Very High (Level 2)
Very High (Level 3)
- New Jersey
- Rhode Island
- Louisiana
- Colorado
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
High (Level 1)
- Massachusetts
- Connecticut
- Michigan
- Idaho
- South Carolina
High (Level 2)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
High (Level 3)
- Washington, D.C.
- Maryland
- North Carolina
- Georgia
The CDC has estimated that there have been at least 4.6 million illnesses, 49,000 hospitalizations and 1,900 flu deaths this season so far. The flu vaccine is recommended as the best line of defense against the virus.
The flu vaccine is recommended as the best line of defense against the virus. (iStock)
In an interview with Fox News Digital, Dr. Neil Maniar, professor of public health practice at Boston’s Northeastern University, shared details on the early severity of this emerging flu strain.
“It’s becoming evident that this is a pretty severe variant of the flu,” he said. “Certainly, in other parts of the world where this variant has been prevalent, it’s caused some severe illness, and we’re seeing an aggressive flu season already.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Subclade K is the “perfect storm” for an aggressive flu season, Maniar suggested, as vaccination rates overall are down, and it’s uncertain whether this year’s flu vaccine directly addresses this specific mutation.
“The vaccine is very important to get, but because it’s not perfectly aligned with this variant, I think that’s also contributing to some degree to the severity of cases we’re seeing,” he said. “We’re going in [to this flu season] with lower vaccination rates and a variant that in itself seems to be more aggressive.”
Subclade K has “caused some severe illness, and we’re seeing an aggressive flu season already,” a doctor said. (iStock)
Maniar stressed that it’s not too late to get the flu vaccine, as peak flu season has not yet arrived.
“The vaccine still provides protection against serious illness resulting from the subclade K variant that seems to be going around,” he said. “There are likely to be lots of indoor gatherings and other events that create risk of exposure, so protection is important.”
CLICK HERE FOR MORE HEALTH STORIES
Even healthy individuals can become seriously ill from the flu, Maniar noted, “so a vaccine is beneficial for almost everyone.”
“Individuals typically start to develop some degree of protection within a few days and gain the full benefit within about two weeks, so now is the time for anyone who hasn’t gotten the vaccine yet.”
NEWYou can now listen to Fox News articles!
Former U.S. Sen. Ben Sasse of Nebraska announced this week that he has been diagnosed with metastatic stage 4 pancreatic cancer, calling the disease “a death sentence” in a message posted on X.
Sasse, 53, said the cancer has spread and acknowledged that he has “less time than I’d prefer,” although he also mentioned recent scientific advances and his intention to pursue treatment.
“I’m not going down without a fight,” Sasse said when revealing his diagnosis. “One sub-part of God’s grace is found in the jaw-dropping advances science has made the past few years in immunotherapy and more.”
HIDDEN FACTOR IN CANCER TREATMENT TIMING MAY AFFECT SURVIVAL, RESEARCHERS SAY
Pancreatic cancer is known to be one of the deadliest forms of cancer, with ongoing research efforts aiming to improve outcomes.
Below are six key things to know about the disease.
No. 1: Pancreatic cancer is often diagnosed late and is highly deadly
Pancreatic cancer is notoriously aggressive and difficult to treat, according to the American Cancer Society. Most patients are not diagnosed until the disease has already spread to other organs, largely because there aren’t reliable screening tests and early symptoms can be vague or absent.
Ben Sasse, a former U.S. senator from Nebraska, announced that he has been diagnosed with metastatic stage 4 pancreatic cancer. (Getty Images; iStock)
The ACS estimates that 67,440 Americans will be diagnosed with pancreatic cancer in 2025, and about 51,980 are expected to die from it. The tumor’s biology creates physical and chemical barriers that reduce the effectiveness of many traditional treatments.
No. 2: New immunotherapies are showing early promise
Researchers at UCLA recently reported progress on an experimental, off-the-shelf, cell-based immunotherapy designed to attack pancreatic cancer.
FORMER GOP SEN. BEN SASSE REVEALS STAGE-4 CANCER DIAGNOSIS: ‘IT’S A DEATH SENTENCE’
In mouse studies, the therapy slowed tumor growth, extended survival and remained effective even after the cancer had spread to other organs, such as the liver and lungs.
The treatment uses special immune cells called natural killer T (NKT) cells, which are genetically modified so they can specifically recognize and attack pancreatic cancer cells.
Early research is exploring new approaches to pancreatic cancer, including experimental immunotherapies and studies of risk factors, but many findings are still in preclinical or observational stages. (iStock)
Unlike personalized therapies, the NKT cells are naturally compatible with different immune systems and can be mass-produced from donor stem cells.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Researchers estimate that one donor could supply cells for thousands of treatments, with a potential cost of around $5,000 per dose. All testing so far has been done in mice, and human trials have not yet begun.
No. 3: Diet and gut health may affect treatment recovery
Separate research from the Massachusetts Institute of Technology has suggested that the amino acid cysteine could help the gut heal after cancer treatments, such as chemotherapy and radiation.
In mouse studies, cysteine — found in foods like meat, eggs, dairy products, legumes and nuts — helped to regenerate intestinal stem cells that are often damaged during cancer therapy.
Researchers are studying how diet, including nutrients such as cysteine found in high-protein foods, may help support recovery from pancreatic cancer treatments. (iStock)
Additional unpublished research showed benefits after treatment with 5-fluorouracil, a chemotherapy drug used for colon and pancreatic cancers.
Researchers emphasized that human studies are still needed and that cysteine is not a cure for cancer itself.
No. 4: Alcohol and lifestyle factors may raise cancer risk
Recent research published in PLOS Medicine by the International Agency for Research on Cancer found that alcohol consumption is associated with an increased risk of pancreatic cancer.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The study followed 2.5 million people for about 16 years, finding that each additional 10 grams of ethanol consumed per day was linked to a 3% increase in risk. Higher intake levels were associated with greater risk, particularly with beer and spirits.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers noted that the study was observational and that more work is needed to understand lifetime drinking patterns.
No. 5: Symptoms are often subtle and easily missed
When symptoms do occur, they can include abdominal pain that spreads to the sides or back, loss of appetite and unexplained weight loss, according to Mayo Clinic.
Some patients develop jaundice — yellowing of the skin and whites of the eyes — along with light-colored or floating stools, dark urine and itching.
Common warning signs of pancreatic cancer can include abdominal pain, unexplained weight loss and loss of appetite. (iStock)
Other possible signs include a new diagnosis of diabetes (or diabetes that becomes harder to control), pain and swelling in an arm or leg that may be linked to a blood clot, and persistent tiredness or weakness.
Those who are experiencing symptoms should consult with a healthcare professional.
No. 6: Age, genetics and health conditions can raise risk
Pancreatic cancer risk is influenced by a combination of genetic, medical and lifestyle factors.
The disease becomes more likely with age, and men are slightly more susceptible, according to the ACS. Those with a family history or inherited genetic mutation also have a higher risk, as do people with type 2 diabetes, obesity and lack of physical activity.
CLICK HERE FOR MORE HEALTH STORIES
Diets high in processed or red meats and low in fruits and vegetables, as well as high alcohol consumption, may also contribute to pancreatic cancer risk, along with some occupational chemical exposures, per multiple cancer agencies.
Experts note, however, that many people are diagnosed with the disease despite having no clear risk factors.
Deirdre Bardolf, Ashley J. DiMella, Alex Nitzberg and Angelica Stabile, all of Fox News Digital, contributed reporting.
NEWYou can now listen to Fox News articles!
The first oral GLP-1 medication for weight loss has been approved for use in the U.S.
The Wegovy pill, from drugmaker Novo Nordisk, was cleared by the Food and Drug Administration to reduce excess body weight, maintain long-term weight reduction and lower the risk of major cardiovascular events.
Approval of the once-daily 25mg semaglutide pill was based on the results of two clinical trials — the OASIS trial program and the SELECT trial.
WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS
The Wegovy pill demonstrated a mean weight loss of 16.6% in the OASIS 4 trial among adults who were obese or overweight and had one or more comorbidities (other medical conditions), according to a press release. In the same trial, one in three participants experienced 20% or greater weight loss.
The first oral GLP-1 medication for weight loss has been approved for use in the U.S. (iStock)
Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile.
WEIGHT LOSS DRUGS COULD ADD YEARS TO AMERICANS’ LIVES, RESEARCHERS PROJECT
“With today’s approval of the Wegovy pill, patients will have a convenient, once-daily pill that can help them lose as much weight as the original Wegovy injection,” said Mike Doustdar, president and CEO of Novo Nordisk, in the press release.
Novo Nordisk reported that the weight loss achieved with the pill is similar to that of injectable Wegovy and has a similar safety profile. (James Manning/PA Images via Getty Images)
“As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight-loss journey.”
POPULAR WEIGHT-LOSS DRUGS COULD TAKE THE EDGE OFF YOUR ALCOHOL BUZZ, STUDY FINDS
The oral GLP-1 is expected to launch in the U.S. in early January 2026. Novo Nordisk has also submitted oral semaglutide for obesity to the European Medicines Agency (EMA) and other regulatory authorities.
“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” an expert said. (iStock)
Dr. Sue Decotiis, a medical weight-loss doctor in New York City, confirmed in an interview with Fox News Digital that studies show oral Wegovy is comparable to the weekly injectable, just without the needles.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Although the pill may result in better compliance and ease of use, Decotiis warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version due to individual idiosyncrasies in the body.
“Most side effects will be GI-related and should be similar to the injectable, such as nausea, vomiting and constipation,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“In my practice, I have found tirzepatide (Mounjaro and Zepbound) to yield more weight loss and fat loss than semaglutide by about 20%,” the doctor added. “This has been shown in studies, often [with] fewer side effects.”
More oral GLP-1s may be coming in 2026, according to Decotiis, including an Orforglipron application by Lilly and a new combination Novo Nordisk drug, which is pending approval later next year.
One expert warned that some patients may not absorb the medication through the gastrointestinal tract as well as with the injectable version. (iStock)
“There will be more new drugs available in the future that will be more effective for patients who are more insulin-resistant and have not responded as well to semaglutide and/or tirzepatide,” the doctor said. “This is great news, as novel drugs affecting more receptors mean better long-term results in more patients.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
As these medications become cheaper and easier to access, Decotiis emphasized that keeping up with healthy lifestyle habits — including proper nutrition with sufficient protein and fiber, as well as increased hydration — is essential to ensuring lasting results.
CLICK HERE FOR MORE HEALTH STORIES
“If not, patients will regain weight and could lose muscle and not enough body fat,” she said.
Fox News Digital reached out to Novo Nordisk for comment.
Powerball fever for estimated $1.7 billion jackpot as warm as the Texas weather
Mia Bailey initially housed with men in prison after Utah murder convictions
Police searching for Vt. woman accused in baby’s drowning death
Nonprofit serves thousands as food insecurity grows in Northern Virginia
Shooting during ICE operation in Maryland leaves 2 injured, officials say
Florida High School Football Rankings: Top 25 teams – Oct. 21
Cleary's 21 help Le Moyne down Central Connecticut State 69-64 in OT
How old is Bo Nix? What to know about Oregon quarterback ahead of 2024 NFL Draft
99th annual Pony Swim held in Virginia
Video: ‘It Didn’t Have to Happen This Way:’ U.Va. Faculty Call for Review of Police Response to Protests
Nearly 20 states sue HHS over declaration to restrict gender transition treatment for minors
Europe defends its digital rules after US targets Breton with visa ban
New Epstein files mention Trump. And, SCOTUS rules on National Guard in Chicago
Nick Fuentes says he’ll campaign against Vivek Ramaswamy in Ohio in slur-laced rant
Libyan army chief killed in plane crash: What next?
-
Iowa1 week agoAddy Brown motivated to step up in Audi Crooks’ absence vs. UNI
-
Maine1 week agoElementary-aged student killed in school bus crash in southern Maine
-
Maryland1 week agoFrigid temperatures to start the week in Maryland
-
New Mexico1 week agoFamily clarifies why they believe missing New Mexico man is dead
-
Massachusetts1 week agoMIT professor Nuno F.G. Loureiro, a 47-year-old physicist and fusion scientist, shot and killed in his home in Brookline, Mass. | Fortune
-
Detroit, MI1 week ago‘Love being a pedo’: Metro Detroit doctor, attorney, therapist accused in web of child porn chats
-
Health1 week ago‘Aggressive’ new flu variant sweeps globe as doctors warn of severe symptoms
-
Maine1 week agoFamily in Maine host food pantry for deer | Hand Off